Are you prepared for the intricacies of government program compliance?
For emerging and existing biotech and pharmaceutical manufacturers, introducing a drug into the government market means navigating the complexities of U.S. government health program requirements.
With up to 50 percent of Americans covered under federally funded programs such as Medicaid, Medicare, the Veterans Administration (VA) and the 340B Drug Pricing Program, government reimbursement programs are an important and growing market segment. However, solving for the accompanying risk and compliance obligations calls for a robust infrastructure—including systems and staff with appropriate program expertise—to support both government and commercial operations.
With so much at stake, many are looking to outside support through a managed services model. KPMG can help you:
- navigate the complexities of program enrollment
- obtain the data needed to advance smarter decision-making
- elevate awareness of post-launch participation and compliance requirements
- build an infrastructure that minimizes costs and advances future growth
- manage post-launch processing activities.
People
Industry professionals with 20+ years of government operations experience.
Process
Build and run a solution to support pre-and post-launch requirements, including:
Phase 1: Program enrollment, methodology development, and systems integration
Phase 2: Operational support, calculations reporting, and claims processing.
Technology and data
Proprietary, automation-driven, and scalable technologies deliver a strong reporting and analytics dashboard with auditable data.
Cost efficiency
Reduce the need to purchase and maintain costly systems and infrastructure with a flexible pricing model and sustainable compliance program.
Learn more in our brochure about how you can focus on your business while KPMG helps you navigate the intricacies and achieve compliance in a highly regulated market, on demand.
